[1]CurrentPatentAssignee:GILEADSCIENCESINC-US2014/336190,2014,A1Locationinpatent:Paragraph1326;1327;1328;1329
[1]CurrentPatentAssignee:ELILILLY&CO-WO2016/77161,2016,A1
[1]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-WO2021/102468,2021,A1
1256788-71-2
374633-36-0
885267-36-7
918793-01-8
1227578-46-2
1806763-56-3
380574-32-3 | 3-[(3,4,5-trimethoxyphenyl)methylidene]-1H,2H,3H-cyclopenta[b]quinoline-9-carboxylic acid | AA00I7F3 | MFCD06654891
391248-14-9 | 4-(Aminomethyl)-1-n-fmoc-piperidine, HCl | AA00I7NA | MFCD02179398
40032-67-5 | 2-Hydroxy-1,2-di(thiophen-3-yl)ethanone | AA00I7RT | MFCD27950378
4102-50-5 | Benzene, 1,5-diiodo-2,4-dimethyl- | AA00I7YD | MFCD29089354
423-50-7 | Perfluorohexane sulphonyl fluoride | AA00I84C | MFCD00042452
438019-67-1 | 2-[1,2,4]Triazol-1-yl-5-trifluoromethyl-phenylamine | AA00I89R | MFCD02712729
454-05-7 | 3'-Trifluoromethylacetophenone semicarbazone | AA00I8FK | MFCD17588465
476004-81-6 | Indole-2-boronic acid pinacol ester | AA00I8LI | MFCD09751284
491-34-9 | 1,2,3,4-Tetrahydro-1-methylquinoline | AA00I8R6 | MFCD00130001
501944-49-6 | 4-(4-tert-butylphenyl)phenylboronic acid | AA00I8WG | MFCD08701731